Despite Price Caps, Indian Pharmaceutical Sales Recover

After dipping this past fall after the implementation of the New Pharma Pricing Policy (NPPP), the overall volume growth has started to rebound. Read more. (Source: Business Standard, 1/19/14).

You might also be interested in:

Value of a QALY for France 08/21/2020
When it Comes to COVID-19 Research, The US Still Has A lot to Learn 09/01/2020
Komodo Health Acquires Mavens 01/20/2021
Democrats Have Their Best Shot Yet at Letting Medicare… 01/21/2021
What Are The Recent Top 4 Innovative Consolidations and… 08/26/2020
Although COVID-19 has Dampened Pharma Sales in 2020, Outlook… 08/17/2020
Capping Out-of-Pocket Costs for Specialty Drugs Reduces… 08/13/2020